BSECompany Update1d ago · 24 Sept 2026, 02:08 pm
Change in Senior Management.
Lincoln Pharmaceuticals Ltd · 531633
✦ AI SummaryMgmt Change
Lincoln Pharmaceuticals Ltd has announced the resignation of Mr. Manoj Rai, Sr. General Manager- QA (Head QA), due to personal reasons, effective September 24, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
3b45b2d8-8cbd-4e45-afa7-a025d10424e6.pdf
View document text
LINCOLN
PHARMACEUTICALS L TO.
HEALTHCARE FOR ALL
Date: September 24, 2026
To, To,
The Manager, Listing Department, The Department of Corporate Service,
National Stock Exchange of India Limited (NSE), BSE Limited,
Exchange Plaza, C – 1, Block – G, Bandra – Kurla 1st Floor, New Trading Ring, Rotunda Building, Phiroze
Complex, Bandra (E), Mumbai-400 051. Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001.
Symbol-LINCOLN Scrip Code-531633
Dear Sir / Madam,
Subject: Intimation of change in Senior Management Personnel under Regulation 30 of Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”).
Pursuant to Regulation 30 read with Schedule III of the LODR Regulations, we hereby inform you that Mr. Manoj
Rai – Sr. General Manager- QA (Head QA) (designated as ‘Senior Management Personnel’) has resigned, due to
personal reasons, with effect from 24th September, 2026, after close of business hours.
Information as required to be disclosed as per SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated
11th November, 2024 are enclosed as Annexure - A.
The copy of the resignation letter setting out the reasons for resignation of Mr. Manoj Rai is enclosed herewith.
Kindly take note of the same on your record.
Thanking you,
Yours faithfully,
For Lincoln Pharmaceuticals Ltd
Trusha Shah
Company Secretary & Compliance Officer
Regd. Office: "Lincoln House", B/h. Satyam Complex, Science City Road, Sola, Ahmedabad-380060, Gujarat, India.
Phone: +91-79-4107 8000 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com I Website : www.lincolnpharma.com
Factory: Trimul Estate, Khatraj, Tai.- Kalal, Dist.- Gandhinagar-382721, Gujarat State. India
Phone: +91-79-4913 5000 I E-mail: khatraj@lincolnpharma.com
LINCOLN
PHARMACEUTICALS L TO.
HEALTHCARE FOR ALL
Annexure - A
Details required under Regulation 30 of the SEBI LODR Regulation
Particulars Mr. Manoj Rai – Sr. General Manager- QA (Head QA)
Reason for change viz. appointment, Resignation due to personal reasons.
re-appointment, resignation, removal,
death or otherwise;
Date of appointment / reappointment / Resignation of Mr. Manoj Rai is effective from
cessation (as applicable) & term of September 24, 2026, after close of business hours.
appointment/re-appointment;
Brief profile (in case of appointment) Not Applicable
Disclosure of relationships between Not Applicable
directors (in case of appointment of a
director)
Regd. Office: "Lincoln House", B/h. Satyam Complex, Science City Road, Sola, Ahmedabad-380060, Gujarat, India.
Phone: +91-79-4107 8000 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com I Website : www.lincolnpharma.com
Factory: Trimul Estate, Khatraj, Tai.- Kalal, Dist.- Gandhinagar-382721, Gujarat State. India
Phone: +91-79-4913 5000 I E-mail: khatraj@lincolnpharma.com
6202 enuJ 31 :etaD
- 'IV lacinhceT
detimiL slacituecamrahP nlocniL
lareneG .rS fo noitisoP eht morf :tcejbuS )AQ noitangiseR daeH( AQ-reganaM
.riS raeD
lareneG .rS fo eht morf ym timbus yllamrof ot ekil dluow noitisop noitangiser - reganaM )AQ AQ I daeH(
.detimiL slacituecamrahP nlocniL ta
ym htiw sngila taht wen a ot dediced evah ,noitaredisnoc luferac rellA ytinutroppo lanoisseforp eusrup I
ym sa ,ysae neeb ton sah noisiced sihT dna reerac snoitaripsa .sevitcejbo htworg lanoisseforp mret-gnol
.gnihcirne dna htob neeb sah detimiL slacituecamrahP nlocniL htiw noitaicossa gnidrawer yllanoisseforp
rof dna ,maeT eht ot erecnis ot ekil dluow seugaelloc ym pihsredaeL ,tnemeganaM edutitarg ym sserpxe I
ehT eht htiw erunet em ot dednetxe dna ,tsurt eht ,ecnadiug .noitazinagro ym gnirud seitinutroppo ,troppus
ot detubirtnoc evah ereh elihw dna deniag erusopxe ecneirepxe lanoisseforp ym yltnacifingis gnikrow
.reerac ot elbaulavni neeb evah dna ym tnempoleved
eciton htnom-eerht eht evres ot ma fo smret eht htiw ecnadrocca nl debircserp ym deraperp ,tnemyolpme I
lla fo revodnah evitceffe eht fo noitisnart htooms a erusne lliw dna gnidulcni ,seitilibisnopser doirep
stnemtimmoc dna ,seitivitca .weivrup ,stcejorp gniogno ymrednu
eht fi eb dluow fo eht ,revewoH lufetarg ,reyolpme evitcepsorp ym stnemeriuqer gninioj gniredisnoc I
evael elbaliava ym gnitsujda reilrae em gniveiler redisnoc dluoc egelivnp/demae yb yldnik tnemeganaM
hcuS .lavorppa dna stnemeriuqer ot eciton eht fo a ecnalab lanoitazinagro tcejbus ,doirep noitrop tsniaga
• eb dluow noitaredisnoc .detaicerppa ylhgih
seitinutroppo dna ,ecnedifnoc eht rof ecno eht knaht ot siht ekat ,troppus niaga noitazinagro ytinutroppo J
ynapmoC eht hsiw .detimiL slacituecamrahP nlocniL htiw noitaicossa em ot ym tuohguorht I dedivorp
.daeha sraey eht ni stnemeveihca dna ,sseccus deunitnoc ,htworg
.egilbo dna noitangiser ym tpecca yldniK
,ylerecnis sruoY
iaR jonat
)AQ daeH( AQ - lareneG .rS reganaM
detimiL slacituecamrahP nlocniL